Axel Künstner

35PUBLICATIONS
161CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|May 13, 2026
Prognostic Value of Regnase-1 in High-Grade Soft Tissue Sarcoma: Favourable in UPS, Yet Inverted in Adjuvantly Irradiated Patients.

|Apr 14, 2026
Adenosine Pathway Activation Defines Genetically Linked Immunosuppressive Subtypes in Solid Tumor Brain Metastases.

Arthur Bauer, Annette Arndt, Luisa Reichenbach

|Mar 27, 2026
IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.

Sonja Bendig, Alina M Hartmann, Wiebke Wessels

|Mar 13, 2026
IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple Myeloma.

Johanna M Horns, Thomas Beder, Axel Künstner

|Feb 12, 2026
Colonic spatial single-cell proteomics and murine models link mitochondrial dysfunction to dimeric IgA-secreting plasma cell deficiency in Crohn's disease.

Annika Raschdorf, Larissa Nogueira de Almeida, Philipp Solbach

|Sep 13, 2025
Impact of Acute Myeloid Leukemia Cells on the Metabolic Function of Bone Marrow Mesenchymal Stem Cells.

Helal Ahmed, Pradeep Kumar Patnana, Yahya S Al-Matary

Pageof 6

Frequent Collaborators

24 joint publications

Hauke Busch

8 joint publications

Niklas Gebauer

7 joint publications

Nikolas von Bubnoff

7 joint publications

Hanno Witte